0000905148-24-001143.txt : 20240409
0000905148-24-001143.hdr.sgml : 20240409
20240409193601
ACCESSION NUMBER: 0000905148-24-001143
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240405
FILED AS OF DATE: 20240409
DATE AS OF CHANGE: 20240409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strobeck Matthew
CENTRAL INDEX KEY: 0001377832
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39659
FILM NUMBER: 24833927
MAIL ADDRESS:
STREET 1: C/O METABOLIX, INC.
STREET 2: 21 ERIE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIODESIX INC
CENTRAL INDEX KEY: 0001439725
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 203986492
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: 303-417-0500
MAIL ADDRESS:
STREET 1: 2970 WILDERNESS PLACE
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
form4.xml
X0508
4
2024-04-05
0001439725
BIODESIX INC
BDSX
0001377832
Strobeck Matthew
919 WEST DILLON RD
LOUISVILLE
CO
80027
true
false
Series A Non-Voting Convertible Preferred Stock
2024-04-05
4
A
0
1304
46
A
Common Stock
52160
1304
I
By Birchview Capital Separately Managed Account
Series A Non-Voting Convertible Preferred Stock
2024-04-05
4
A
0
7392
46
A
Common Stock
295680
7392
I
By Birchview Fund LLC
These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer has agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its 2024 annual meeting of stockholders (the "Conversion Proposal"). Following such approval of the Conversion Proposal, each share of Preferred Stock will automatically convert into 40 shares of Common Stock, subject to certain limitations, including that the Reporting Person is prohibited from converting shares of Preferred Stock into shares of Common Stock if, as a result of such conversion, the Reporting Person, together with his affiliates, would beneficially own more than 19.9% of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Preferred Stock has no expiration date.
The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck
2024-04-09